Before a breast cancer patient heads into surgery, her care team runs through a long checklist. Heart function, blood count, medication allergies – but typically not vitamin D, even though its deficiency may amplify pain during recovery.
Researchers at a hospital in Egypt wondered what that omission might mean. They followed breast cancer patients through mastectomy and the difficult 24 hours that came after, measuring something most surgical protocols overlook.
A simple deficiency
Mahdy Ahmed Abdelhady, M.D., Ph.D., of Fayoum University in Egypt, led a team that wanted to know whether a single blood marker could predict how much pain a patient would feel after surgery. They chose a demanding recovery to study.
Vitamin D deficiency turns up more often in women with breast cancer than in the general population. That overlap had nagged at clinicians for years without anyone pinning down what, if anything, it changed about treatment outcomes.
Among 184 patients, half had vitamin D levels below the deficiency threshold. The rest sat above it. Other variables – age, surgical plan, baseline health – matched across both groups, with averages in the low 40s.
Tracking pain by hour
The study ran at the university’s hospital from September 2024 through April 2025.
Every patient was scheduled for a mastectomy – the surgical removal of an entire breast – a major procedure with a slow recovery.
Doctors and nurses on the floor did not know which group a patient belonged to.
Everyone received the same pain management plan – fentanyl, an opioid painkiller, during the operation, and intravenous acetaminophen on a fixed schedule afterward.
Patients controlled their own additional pain relief through a button-activated pump dispensing tramadol, an opioid. Nurses recorded pain on a 0-to-10 scale right after surgery and at four points across the next 24 hours.
Three times more pain
The primary measure was postoperative pain at the 12-hour mark, scored above three on the standard scale. Patients in the deficient group were roughly three times more likely to land in that range than patients with sufficient levels.
None of the women in either group reported severe pain – seven or higher on the scale. The gap came entirely from the moderate band of four to six, the level where a patient hurts enough to want more relief.
That detail adds important context. Deficient patients did not push into emergency-level pain, only into the steady ache of moderate scores – the kind that keeps a recovering patient reaching for the button every few hours.
Opioids fill the gap
The clearest divide showed up in opioid use. During the operation itself, deficient patients needed only about 8 micrograms more fentanyl than the others – a modest bump the team did not consider clinically meaningful on its own.
After surgery, the difference widened sharply. Patients with low vitamin D pressed the button often enough to take in an average of 112 milligrams more tramadol over the first day than patients with adequate levels.
Nausea also tracked with deficiency. More patients in the low-vitamin group reported it during recovery, consistent with the heavier opioid load they were carrying. Vomiting showed up only in that group, though the numbers were too small to call statistically significant.
Vitamin D and surgery pain
Researchers had gathered evidence before this work that vitamin D does more than support bones. Earlier papers on chronic back pain and gallbladder surgery recovery had linked low levels to higher pain scores – not always consistently, but the pattern kept appearing.
The mechanism appears to run through inflammation. Vitamin D is thought to quiet chemical signals that dial up sensitivity in injured tissue, and a recent paper has tied that effect to its action on immune cells and the molecules that amplify pain.
Postoperative breast cancer pain joins that growing list. Until this study, no one had measured the relationship in this specific patient population, where vitamin D deficiency is already common before the diagnosis.
Limits of the study
Abdelhady’s team is upfront about what the design cannot do. An observational study – even a careful one – cannot prove the deficiency itself caused worse recovery, only that the two travel together in this group of patients.
Several variables were not included in the analysis. Mental health, cancer stage, prior treatments, and sleep quality all affect how pain registers in the body. The team collected data on none of them, and any of those gaps could partly explain the difference.
Blood samples were not drawn to measure inflammation levels either. Without that data, the proposed mechanism remains a credible hypothesis rather than something the numbers directly confirmed. Testing it will require a different study design.
What could change
Even with those gaps, the practical question for clinicians lies in a simple intervention. A vitamin D blood test is cheap, fast, and already routine. Supplementation, when needed, is one of the simplest steps in medicine.
If a clinical trial of preoperative dosing in deficient patients confirmed the link, breast cancer surgery centers could build the check into standard preparation. Patients walking into an operating room with corrected levels might face less pain and fewer opioids afterward.
This study establishes a clear pattern. Low vitamin D before breast cancer surgery travels with more pain and heavier opioid use after. The next study will not be a question of whether to run it, only of how soon.
The study is published in the journal Regional Anesthesia & Pain Medicine.
—–
Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates.
Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.
—–